Pain Management Techniques for ACL Surgery
Trial Summary
What is the purpose of this trial?
This trial compares pain control methods for ACL surgery patients, using either a nerve block or oral medications. It aims to see if both methods provide similar pain relief and recovery outcomes. The study will also assess the cost-effectiveness and patient flow logistics of each method.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Adductor Canal Nerve Block for pain management in ACL surgery?
Is the adductor canal nerve block safe for pain management in ACL surgery?
How is the adductor canal nerve block treatment different from other pain management techniques for ACL surgery?
Research Team
Cassandra Lee, MD
Principal Investigator
UC-Davis Health
Eligibility Criteria
This trial is for adults aged 18-45 who have confirmed ACL tears and are recommended to undergo reconstructive surgery. It's not suitable for those unable to consent, pregnant women, individuals with inflammatory arthritis, non-English speakers, anyone with prior knee surgeries, or prisoners.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants complete the Brief Resiliency Scale questionnaire and receive pre-operative pain medication prescriptions
Surgery and Immediate Post-op
Participants undergo ACL reconstruction surgery and complete a Visual Analog Scale for pain assessment in the recovery room
Post-operative Treatment
Participants follow a prescribed pain medication regimen and maintain a pain diary for 6 weeks
Follow-up
Participants complete the Knee Injury and Osteoarthritis Outcome Score at 3 months and the Marx Activity Rating Scale at 6 months to assess knee function
Treatment Details
Interventions
- Adductor Canal Nerve Block
- Ropivacaine injection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor